ANTHERA PHARMACEUTICALS Stock Price
$0.5999 
Change:
0.02 1.63% Volume:
7,400
Live Stock Prices
You need Flash Player to see the chart, please download from the link below
Todays Chart
You need Flash Player to see the chart, please download from the link below
Month Chart
Todays High: 0.608 | Todays Low: 0.581 | Open: 0.581 | Last Close: 0.607
52 Wk High: 3.19 | 52 Wk Low: 0.5 | Todays Pivot: 0.60 | Pre market open: 0.64
Sector: 
Online News For Anthera Pharmaceuticals
|
Cytori Therapeutics Inc (NASDAQ:CYTX) up by 2.80%, Anthera Pharmaceuticals ... - GSPInsider
Tue, 21 May 2013 18:25Anthera Pharmaceuticals Inc (NASDAQ:ANTH): In Tuesday's trading session, Anthera Pharmaceuticals Inc (NASDAQ:ANTH) jumped 0.59%. Its opening price of $0.91 was also the intraday high, which eventually headed down to currently trade at $0.583 per ...
|
|
Exide Technologies (NASDAQ:XIDE) loses 44.49% of its market cap, Anthera ... - NIS
Fri, 24 May 2013 17:09Anthera Pharmaceuticals Inc (NASDAQ:ANTH) is now down 0.91% to currently hover around $0.601. The stock has seen a volume of 0.344 million in the current trading session so far, the average volume in the stock over a period of 90 days is 778.46K. At ...
|
|
Anthera Pharmaceuticals Reports 2013 First Quarter Financial Results - PharmaLive (press release) (subscription)
Tue, 14 May 2013 18:46Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases. Anthera's Phase 3 development product candidate, blisibimod, targets elevated levels of B-cell activating ...
|
|
Anthera Pharmaceuticals Management Discusses Q1 2013 Results - Earnings ... - Seeking Alpha
Mon, 20 May 2013 23:31Good day, ladies and gentlemen, and thank you for standing by, and welcome to the Anthera's First Quarter Corporate Update Conference Call. [Operator Instructions] I would now like to turn the call over and introduce Chris Lowe, Anthera's Chief ...
|
|
Anthera Pharmaceuticals Announces Additional Data from Phase 2b PEARL-SC ... - PR Newswire (press release)
Tue, 07 May 2013 20:32HAYWARD, Calif., May 7, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases, today announced that additional data from its ...
|
|
ANTHERA PHARMACEUTICALS INC : Anthera Announces First Quarter 2013 ... - 4-traders (press release)
Fri, 03 May 2013 18:10HAYWARD, Calif., May 3, 2013 /PRNewswire/ -- Anthera Pharmaceuticals, Inc. (Nasdaq: ANTH), a biopharmaceutical company focused on developing and commercializing products to treat autoimmune diseases, will release its first quarter 2013 financial ...
|
ANTH Chart
You need Flash Player to see the chart, please download from the link below
Want To Add This Quote To Your Site?
With our stock widgets you can add a real time Anthera Pharmaceuticals quote to your website to keep your users up to date with the market. We have a variety of different styled widgets for ANTH to choose from. Visit here to build your stock quote widget »
